Insider Purchases of Penny Stocks -
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-11-12 | ACRX | Acelrx Pharmaceuticals Inc | Edwards Mark G | Dir | P - Purchase | $1.78 | +25,000 | 243,750 | +11% | +$44,575 | ||||||
2019-11-11 | ACRX | Acelrx Pharmaceuticals Inc | Angotti Vincent J. | CEO | P - Purchase | $1.79 | +8,379 | 275,944 | +3% | +$14,973 | ||||||
| M | 2019-11-21 | ACY | Aerocentury Corp | Magnusson Michael Gerhard | Pres | P - Purchase | $4.07 | +15,000 | 15,000 | New | +$60,983 | |||||
| M | 2019-11-14 | AGRX | Agile Therapeutics Inc | Perceptive Advisors LLC | 10% | P - Purchase | $1.68 | +5,768,815 | 11,919,925 | +94% | +$9,675,987 | |||||
2019-11-20 | AKBA | Akebia Therapeutics, Inc. | Gilman Steven C | Dir | P - Purchase | $3.43 | +5,800 | 29,731 | +24% | +$19,894 | ||||||
2019-11-20 | AKBA | Akebia Therapeutics, Inc. | Smith Cynthia | Dir | P - Purchase | $3.52 | +15,000 | 28,700 | +109% | +$52,800 | ||||||
2019-11-20 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | P - Purchase | $3.58 | +27,000 | 37,000 | +270% | +$96,660 | ||||||
2019-11-20 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres | P - Purchase | $3.44 | +50,000 | 1,069,682 | +5% | +$172,000 | ||||||
2019-11-20 | AKBA | Akebia Therapeutics, Inc. | Adams Adrian | Dir | P - Purchase | $3.41 | +50,000 | 63,700 | +365% | +$170,500 | ||||||
2019-11-21 | ALIM | Alimera Sciences Inc | Snisarenko John | Dir | P - Purchase | $4.95 | +10,000 | 10,000 | New | +$49,500 | ||||||
| A | 2019-11-14 | ALIM | Alimera Sciences Inc | Eiswirth Richard S Jr | Pres, CEO | P - Purchase | $0.30 | +100,000 | 463,901 | +27% | +$29,890 | |||||
2019-11-12 | ALRN | Aileron Therapeutics Inc | Bailey Jeffrey Allen | Dir | P - Purchase | $0.53 | +19,894 | 19,894 | New | +$10,544 | ||||||
| M | 2019-11-14 | ALRN | Aileron Therapeutics Inc | Bailey Jeffrey Allen | Dir | P - Purchase | $0.51 | +55,000 | 74,894 | +276% | +$28,050 | |||||
2019-12-05 | ALSK | Alaska Communications Systems Group Inc | Aquino Peter D | Dir | P - Purchase | $1.73 | +15,000 | 15,000 | New | +$25,932 | ||||||
| A | 2019-11-27 | ALTD | Altitude International, Inc | Kanuth Robert | CEO, 10% | P - Purchase | $0.04 | +1,000,000 | 10,129,816 | +11% | +$35,000 | |||||
2019-11-27 | ALTD | Altitude International, Inc | Kanuth Robert | CEO, 10% | P - Purchase | $0.35 | +1,000,000 | 10,129,816 | +11% | +$350,000 | ||||||
2019-11-19 | ALTM | Altus Midstream Co | Bretches D. Clay | CEO | P - Purchase | $1.69 | +20,000 | 160,000 | +14% | +$33,800 | ||||||
2019-11-22 | APTX | Aptinyx Inc. | Hombach Robert J. | Dir | P - Purchase | $3.23 | +50,000 | 99,100 | +102% | +$161,750 | ||||||
| A | 2019-11-08 | AR | Antero Resources Corp | Clark Robert J | Dir | P - Purchase | $2.79 | +178,000 | 244,889 | +266% | +$496,353 | |||||
| M | 2019-12-05 | ARC | Arc Document Solutions, Inc. | Mealy Mark W | Dir | P - Purchase | $1.10 | +50,000 | 206,645 | +32% | +$55,229 | |||||
2019-11-11 | ARLO | Arlo Technologies, Inc. | McRae Matthew Blake | CEO | P - Purchase | $2.73 | +36,600 | 319,799 | +13% | +$99,753 | ||||||
2019-11-11 | ARLO | Arlo Technologies, Inc. | Faison Ralph E | Dir | P - Purchase | $2.88 | +36,000 | 182,725 | +25% | +$103,680 | ||||||
2019-11-12 | ASRT | Assertio Therapeutics, Inc | Higgins Arthur J | Dir, Pres, CEO | P - Purchase | $0.73 | +25,000 | 290,879 | +9% | +$18,250 | ||||||
| DM | 2019-11-15 | AVDL | Avadel Pharmaceuticals Plc | Glass Geoffrey Michael | Dir | P - Purchase | $4.99 | +20,000 | 47,900 | +72% | +$99,800 | |||||
| D | 2019-11-15 | AVDL | Avadel Pharmaceuticals Plc | Ende Eric J | Dir | P - Purchase | $4.98 | +10,000 | 37,900 | +36% | +$49,762 | |||||
2019-11-21 | AVEO | Aveo Pharmaceuticals Inc | Bailey Michael P | Pres, CEO | P - Purchase | $0.60 | +150,000 | 318,848 | +89% | +$89,595 | ||||||
2019-11-18 | AWRE | Aware Inc /ma/ | Ronin Capital, LLC | 10% | P - Purchase | $2.95 | +15,500 | 4,572,182 | 0% | +$45,716 | ||||||
| M | 2019-11-13 | AWRE | Aware Inc /ma/ | Ronin Capital, LLC | 10% | P - Purchase | $2.89 | +6,625 | 4,556,682 | 0% | +$19,150 | |||||
| DM | 2019-11-20 | AWRE | Aware Inc /ma/ | Eckel Robert A | CEO, Pres | P - Purchase | $3.34 | +6,383 | 32,269 | +25% | +$21,329 | |||||
| M | 2019-11-07 | AWRE | Aware Inc /ma/ | Ronin Capital, LLC | 10% | P - Purchase | $2.90 | +31,497 | 4,550,057 | +1% | +$91,318 | |||||
| M | 2019-11-26 | AXLA | Axcella Health Inc. | Epstein David R | Dir | P - Purchase | $3.57 | +15,005 | 53,298 | +39% | +$53,630 | |||||
| M | 2019-11-26 | AXLA | Axcella Health Inc. | Epstein David R | Dir | P - Purchase | $3.57 | +15,005 | 53,298 | +39% | +$53,630 | |||||
2019-12-02 | BBGI | Beasley Broadcast Group Inc | Beasley Caroline | CEO, 10% | P - Purchase | $2.85 | +5,000 | 236,782 | +2% | +$14,250 | ||||||
2019-11-18 | BCRX | Biocryst Pharmaceuticals Inc | Barnes Alane P | SVP, GC | P - Purchase | $1.45 | +20,000 | 102,061 | +24% | +$29,000 | ||||||
2019-11-18 | BCRX | Biocryst Pharmaceuticals Inc | Babu Yarlagadda S | SVP - Drug Discovery | P - Purchase | $1.45 | +25,000 | 155,587 | +19% | +$36,250 | ||||||
2019-11-18 | BCRX | Biocryst Pharmaceuticals Inc | Aselage Steve | Dir | P - Purchase | $1.45 | +15,000 | 21,672 | +225% | +$21,750 | ||||||
2019-11-18 | BCRX | Biocryst Pharmaceuticals Inc | Stonehouse Jon P | Pres, CEO | P - Purchase | $1.45 | +50,000 | 778,086 | +7% | +$72,500 | ||||||
2019-11-18 | BCRX | Biocryst Pharmaceuticals Inc | Sniecinski Megan | Chief Business Officer | P - Purchase | $1.45 | +45,000 | 45,000 | New | +$65,250 | ||||||
2019-11-18 | BCRX | Biocryst Pharmaceuticals Inc | Ingram Robert Alexander | Dir | P - Purchase | $1.45 | +20,000 | 48,088 | +71% | +$29,000 | ||||||
2019-11-18 | BCRX | Biocryst Pharmaceuticals Inc | Hutson Nancy J | Dir | P - Purchase | $1.45 | +10,000 | 53,046 | +23% | +$14,500 | ||||||
2019-11-01 | BGFT | Bigfoot Project Investments Inc | Biscardi Carmine T | CEO | P - Purchase | $0.00 | +500,000,000 | 730,790,000 | +217% | +$500,000 | ||||||
2019-12-03 | BKCC | Blackrock Capital Investment Corp | Pungello Michael | Interim CFO, Interim Treasurer | P - Purchase | $4.99 | +5,000 | 24,583 | +26% | +$24,949 | ||||||
2019-12-02 | BKCC | Blackrock Capital Investment Corp | Keenan James | Interim CEO | P - Purchase | $4.94 | +30,279 | 121,279 | +33% | +$149,515 | ||||||
2019-11-13 | BKEP | Blueknight Energy Partners, L.P. | Woodward D Andrew | CFO | P - Purchase | $1.14 | +50,000 | 96,168 | +108% | +$56,906 | ||||||
2019-11-27 | BMTM | Bright Mountain Media, Inc. | Speyer W Kip | CEO, COB, 10% | P - Purchase | $1.64 | +7,028 | 29,611,630 | 0% | +$11,526 | ||||||
| M | 2019-11-12 | BSQR | Bsquare Corp /wa | Vardeman Ryan L. | Member of 10% Group | P - Purchase | $1.28 | +66,868 | 1,303,603 | +5% | +$85,851 | |||||
2019-11-19 | BSQR | Bsquare Corp /wa | Vardeman Ryan L. | Member of 10% Group | P - Purchase | $1.28 | +33,132 | 1,336,735 | +3% | +$42,541 | ||||||
| M | 2019-11-21 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.60 | +4,882 | 3,958,277 | 0% | +$12,678 | |||||
| M | 2019-11-14 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.81 | +7,503 | 3,941,457 | 0% | +$21,105 | |||||
| M | 2019-11-18 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.81 | +11,938 | 3,953,395 | 0% | +$33,503 | |||||
2019-11-13 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.83 | +4,600 | 3,933,954 | 0% | +$13,018 | ||||||
2019-11-20 | BVSN | Broadvision Inc | Esw Capital, LLC | 10% | P - Purchase | $2.50 | +7,371 | 1,059,128 | +1% | +$18,428 | ||||||
2019-11-25 | BVSN | Broadvision Inc | Esw Capital, LLC | 10% | P - Purchase | $2.50 | +7,350 | 1,066,478 | +1% | +$18,375 | ||||||
| M | 2019-11-12 | BVSN | Broadvision Inc | Esw Capital, LLC | 10% | P - Purchase | $2.48 | +6,450 | 1,051,757 | +1% | +$15,966 | |||||
2019-11-20 | CALA | Calithera Biosciences, Inc. | Bvf Partners L P/il | 10% | P - Purchase | $3.91 | +191,954 | 672,682 | +40% | +$750,847 | ||||||
2019-11-14 | CALA | Calithera Biosciences, Inc. | Bvf Partners L P/il | 10% | P - Purchase | $3.37 | +128,488 | 658,531 | +24% | +$433,005 | ||||||
2019-11-11 | CASA | Casa Systems Inc | Hayashi Michael T | Dir | P - Purchase | $3.44 | +3,000 | 10,061 | +42% | +$10,320 | ||||||
2019-12-04 | CBL | Cbl & Associates Properties Inc | Ashner Michael L | Dir | P - Purchase | $1.04 | +1,000,000 | 11,350,000 | +10% | +$1,040,000 | ||||||
2019-12-03 | CDEV | Centennial Resource Development, Inc. | O'Connor Davis O | VP, GC | P - Purchase | $3.03 | +10,000 | 294,861 | +4% | +$30,291 | ||||||
| M | 2019-11-15 | CDEV | Centennial Resource Development, Inc. | Glyphis George S. | VP, CFO | P - Purchase | $3.14 | +37,500 | 568,195 | +7% | +$117,757 | |||||
2019-11-15 | CDEV | Centennial Resource Development, Inc. | Papa Mark G | CEO | P - Purchase | $3.44 | +100,000 | 2,063,817 | +5% | +$343,600 | ||||||
| M | 2019-11-08 | CDEV | Centennial Resource Development, Inc. | Shapiro Steven J | Dir | P - Purchase | $3.42 | +50,000 | 59,567 | +523% | +$171,125 | |||||
| M | 2019-11-08 | CDEV | Centennial Resource Development, Inc. | Glyphis George S. | VP, CFO | P - Purchase | $3.35 | +37,500 | 530,695 | +8% | +$125,571 | |||||
2019-11-14 | CDXC | Chromadex Corp. | Fried Robert N | CEO | P - Purchase | $3.09 | +10,000 | 1,457,061 | +1% | +$30,900 | ||||||
2019-11-11 | CEMI | Chembio Diagnostics, Inc. | Potthoff John Gary | Dir | P - Purchase | $4.44 | +10,000 | 37,772 | +36% | +$44,400 | ||||||
2019-11-14 | CHK | Chesapeake Energy Corp | Buergler William M | SVP, Chief Accounting Officer | P - Purchase | $0.71 | +70,681 | 478,902 | +17% | +$50,056 | ||||||
2019-12-06 | CHK | Chesapeake Energy Corp | Ryan Thomas L | Dir | P - Purchase | $0.75 | +200,000 | 1,108,531 | +22% | +$150,000 | ||||||
2019-11-20 | CKPT | Checkpoint Therapeutics, Inc. | Rosenwald Lindsay A Md | Dir | P - Purchase | $1.27 | +100,000 | 237,890 | +73% | +$127,000 | ||||||
2019-11-11 | CLSD | Clearside Biomedical, Inc. | Lasezkay George M | CEO | P - Purchase | $1.16 | +12,000 | 222,000 | +6% | +$13,920 | ||||||
| M | 2019-11-11 | CMRX | Chimerix Inc | Middleton Fred A | Dir | P - Purchase | $1.76 | +50,000 | 3,458,923 | +1% | +$87,757 | |||||
2019-11-20 | CMT | Core Molding Technologies Inc | Palomaki Eric | EVP,Operations | P - Purchase | $3.13 | +5,000 | 38,874 | +15% | +$15,650 | ||||||
2019-11-29 | CMT | Core Molding Technologies Inc | Jauchius Matthew | Dir | P - Purchase | $3.55 | +13,000 | 49,563 | +36% | +$46,150 | ||||||
| M | 2019-11-20 | CMT | Core Molding Technologies Inc | Duvall David L. | CEO | P - Purchase | $3.06 | +10,000 | 166,697 | +6% | +$30,650 | |||||
2019-11-11 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Discordia Robert Paul | COO | P - Purchase | $4.62 | +2,500 | 32,650 | +8% | +$11,559 | ||||||
2019-11-12 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | White Barbara | Chief Medical Officer | P - Purchase | $4.38 | +3,424 | 190,611 | +2% | +$14,992 | ||||||
| M | 2019-11-12 | CRVS | Corvus Pharmaceuticals, Inc. | Miller Richard A Md | Pres, CEO | P - Purchase | $3.00 | +15,008 | 1,178,515 | +1% | +$45,029 | |||||
2019-12-06 | CTSO | Cytosorbents Corp | Chan Phillip P. | Pres, CEO | P - Purchase | $3.60 | +16,500 | 657,688 | +3% | +$59,400 | ||||||
| M | 2019-11-21 | CUI | Cui Global, Inc. | Oneil James F | CEO | P - Purchase | $0.99 | +20,000 | 450,331 | +5% | +$19,900 | |||||
2019-11-15 | CUI | Cui Global, Inc. | Oneil James F | CEO | P - Purchase | $0.98 | +50,000 | 380,331 | +15% | +$48,960 | ||||||
2019-11-19 | CUI | Cui Global, Inc. | Oneil James F | CEO | P - Purchase | $1.08 | +50,000 | 430,331 | +13% | +$54,000 | ||||||
2019-12-09 | CUI | Cui Global, Inc. | Oneil James F | CEO | P - Purchase | $1.13 | +20,000 | 475,212 | +4% | +$22,600 | ||||||
2019-11-14 | CVLB | Conversion Labs, Inc. | Schreiber Justin | CEO, 10% | P - Purchase | $0.17 | +75,000 | 9,479,310 | +1% | +$12,494 | ||||||
2019-11-08 | CVLB | Conversion Labs, Inc. | Walters Happy David | Dir | P - Purchase | $0.18 | +200,000 | 425,000 | +89% | +$36,180 | ||||||
2019-11-08 | CVSI | Cv Sciences, Inc. | Dowling Joseph D | CEO | P - Purchase | $1.65 | +15,000 | 15,000 | New | +$24,750 | ||||||
2019-11-15 | CYCN | Cyclerion Therapeutics, Inc. | Busch Andreas | Chief Innovation Officer | P - Purchase | $1.82 | +125,000 | 125,000 | New | +$227,500 | ||||||
2019-11-25 | DPDW | Deep Down, Inc. | Smith Ronald Eric | 10% | P - Purchase | $0.66 | +169,191 | 710,562 | +31% | +$111,666 | ||||||
2019-11-19 | DRTT | Dirtt Environmental Solutions Ltd | Lillibridge Todd W. | Dir | P - Purchase | $3.04 | +20,000 | 110,700 | +22% | +$60,720 | ||||||
2019-11-22 | DRTT | Dirtt Environmental Solutions Ltd | Elliott John | Dir | P - Purchase | $3.27 | +10,000 | 45,400 | +28% | +$32,700 | ||||||
2019-11-15 | DRTT | Dirtt Environmental Solutions Ltd | Calkins Jeffrey | COO | P - Purchase | $3.21 | +9,400 | 9,400 | New | +$30,202 | ||||||
2019-11-20 | DRTT | Dirtt Environmental Solutions Ltd | Krause Geoffrey D. | CFO | P - Purchase | $3.07 | +4,850 | 23,332 | +26% | +$14,877 | ||||||
2019-11-18 | DRTT | Dirtt Environmental Solutions Ltd | Karkkainen Denise | Dir | P - Purchase | $3.13 | +3,600 | 26,900 | +15% | +$11,268 | ||||||
| M | 2019-11-20 | DRTT | Dirtt Environmental Solutions Ltd | Lillibridge Todd W. | Dir | P - Purchase | $3.06 | +45,000 | 155,700 | +41% | +$137,700 | |||||
2019-11-20 | DRTT | Dirtt Environmental Solutions Ltd | Karkkainen Denise | Dir | P - Purchase | $3.06 | +6,400 | 33,300 | +24% | +$19,584 | ||||||
| M | 2019-11-18 | DRTT | Dirtt Environmental Solutions Ltd | Omeara Kevin P | See Remarks | P - Purchase | $3.06 | +11,930 | 36,930 | +48% | +$36,476 | |||||
2019-11-20 | DRTT | Dirtt Environmental Solutions Ltd | Omeara Kevin P | See Remarks | P - Purchase | $3.08 | +13,070 | 50,000 | +35% | +$40,236 | ||||||
| M | 2019-11-14 | DS | Drive Shack Inc. | Acacia Research Corp | Dir | P - Purchase | $4.15 | +500,000 | 591,600 | +546% | +$2,076,283 | |||||
2019-11-20 | DSE | Duff & Phelps Select Mlp & Midstream Energy Fund Inc. | Georgas Charles John | Portfolio Manager | P - Purchase | $3.36 | +3,000 | 10,688 | +39% | +$10,080 | ||||||
2019-11-26 | DXLG | Destination Xl Group, Inc. | Holtzman Seymour | Dir | P - Purchase | $1.32 | +20,000 | 4,757,018 | 0% | +$26,450 | ||||||
2019-11-27 | DXLG | Destination Xl Group, Inc. | Holtzman Seymour | Dir | P - Purchase | $1.22 | +20,000 | 4,777,018 | 0% | +$24,400 | ||||||
2019-11-27 | DXLG | Destination Xl Group, Inc. | Kanter Harvey S | Pres, CEO | P - Purchase | $1.27 | +10,000 | 40,000 | +33% | +$12,700 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |